AI for Cancer: How to Invest

This comes straight from an MIT report........................................................................................................................................................................................................................................... [Unsubscribe]( Dear Member, You probably know how artificial intelligence is disrupting businesses all over the country. But were you aware of how rapidly it's also disrupting science and medicine? Right now, doctors are using AI systems like Exscientia to offer personalized medicine that no one ever dreamed possible. In fact, this AI technology actually just saved an 82-year-old man in Austria with blood cancer. After six rounds of chemotherapy, the patient was out of options. But when Exscientia analyzed the patient's unique genetic profile, it recommended a drug that most doctors thought was ineffective against cancer … And it worked. Two years later, this man's cancer was in complete remission. AI was able to figure out the right medicine even when the world's best doctors didn't have a clue. And that's just the beginning. Biotech companies are using AI to design new drugs at the molecular level completely from scratch. And soon, AI will perform the diagnosis and recommend the right treatment without your doctor. I know it sounds crazy, but AI is advancing with lightning speed. That's why I'm convinced that AI is the biggest opportunity for investors in decades. It will reshape every industry and change our lives in ways we never imagined, just like the internet did 30 years ago. In fact, we estimate that the opportunity in AI-assisted healthcare alone could be far bigger than the AI apps we've seen so far. To get all the details, [watch my urgent briefing, "The Next AI Bonanza: 100x Larger than GPT]( Warm Regards, [Martin D. Weiss] Martin D. Weiss, PhD Weiss Ratings Founder 11780 US Highway 1, Palm Beach Gardens, FL 33408-3080 Would you like to [edit your e-mail notification preferences or unsubscribe]( from our mailing list? Copyright © 2023 Weiss Ratings. All rights reserved. --------------------------------------------------------------- This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click [Unsubscribe]( . StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com